SOD1, APP, and APOE drive amyloid pathology in the brain and spinal cord, while amyloidosis-resulted neuroinflammation and cell death are mediated by TP53, IL6, CASP3, IL1B, and VEGFA. Here, APP is linked to amyloidosis.